• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗器械评估中的化学特性:当前实践、法规要求及未来方向

Chemical Characterization in Medical Device Evaluation: Current Practices, Regulatory Requirements, and Future Directions.

作者信息

Szymanski Lukasz, Kiernozek Magdalena, Gromadka Bartosz, Straszecka Weronika, Wiktorek-Smagur Aneta, Matak Damian

机构信息

Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36A, 05-552, Magdalenka, Poland.

European Biomedical Institute, Nalkowskiej 5, 05-410, Jozefow, Poland.

出版信息

Ann Biomed Eng. 2025 May;53(5):1068-1079. doi: 10.1007/s10439-025-03702-5. Epub 2025 Mar 4.

DOI:10.1007/s10439-025-03702-5
PMID:40035968
Abstract

The rigorous regulatory landscape for medical devices demands meticulous chemical characterization to ensure safety and compliance. This review examines the critical role of chemical characterization within regulatory frameworks, emphasizing its importance in the approval and market entry of medical devices. Key challenges, including the complexity of sample matrices, trace-level impurity detection, and the necessity of method validation, are thoroughly explored. In addition, the review addresses the dynamic nature of regulatory requirements, analyzing how updates in international standards, such as those from the International Organization for Standardization (ISO), the American National Standards Institute (ANSI), and the Association for the Advancement of Medical Instrumentation (AAMI), or the American Society for Testing and Materials (ASTM), shape the chemical characterization process. The review discusses future directions, including advancements in analytical technologies, the potential for increased automation and standardization, and the growing significance of managing emerging contaminants. By offering a comprehensive analysis of current practices and future trends, this review highlights the essential role of chemical characterization in ensuring the development and regulation of safe and effective medical devices.

摘要

医疗器械严格的监管环境要求进行细致的化学表征,以确保安全性和合规性。本综述探讨了化学表征在监管框架中的关键作用,强调了其在医疗器械批准和进入市场过程中的重要性。全面探讨了关键挑战,包括样品基质的复杂性、痕量杂质检测以及方法验证的必要性。此外,本综述还讨论了监管要求的动态性质,分析了国际标准(如国际标准化组织(ISO)、美国国家标准学会(ANSI)、医疗仪器促进协会(AAMI)或美国材料与试验协会(ASTM))的更新如何塑造化学表征过程。本综述讨论了未来的方向,包括分析技术的进步、自动化和标准化程度提高的潜力以及管理新兴污染物的重要性日益增加。通过对当前实践和未来趋势进行全面分析,本综述突出了化学表征在确保安全有效的医疗器械的开发和监管方面的重要作用。

相似文献

1
Chemical Characterization in Medical Device Evaluation: Current Practices, Regulatory Requirements, and Future Directions.医疗器械评估中的化学特性:当前实践、法规要求及未来方向
Ann Biomed Eng. 2025 May;53(5):1068-1079. doi: 10.1007/s10439-025-03702-5. Epub 2025 Mar 4.
2
Ensuring Medical Device Safety: The Role of Standards Organizations and Regulatory Bodies.确保医疗器械安全:标准组织和监管机构的作用。
J Med Syst. 2025 Jan 25;49(1):16. doi: 10.1007/s10916-025-02150-x.
3
Improving medical device regulation: the United States and Europe in perspective.改进医疗器械监管:美国和欧洲的视角。
Milbank Q. 2014 Mar;92(1):114-50. doi: 10.1111/1468-0009.12043.
4
Medical device regulation for manufacturers.针对制造商的医疗器械监管
Proc Inst Mech Eng H. 2003;217(6):459-67. doi: 10.1243/09544110360729090.
5
Evaluating the Impact of the EU AI Act on Medical Device Regulation.评估欧盟人工智能法案对医疗器械监管的影响。
Stud Health Technol Inform. 2025 Apr 8;323:40-44. doi: 10.3233/SHTI250045.
6
Modernizing Medical Device Regulation: Challenges and Opportunities for the 510(k) Clearance Process.医疗器械监管现代化:510(k) 审批流程面临的挑战与机遇。
Ann Intern Med. 2024 Nov;177(11):1558-1565. doi: 10.7326/ANNALS-24-00728. Epub 2024 Oct 8.
7
[Comments and suggestions on the medical device standardization system from the view point of medical devices test].从医疗器械检测角度对医疗器械标准化体系的评论与建议
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Jun;30(3):546-51.
8
Navigating AAMI ST108 Water Quality Requirements for Safe Processing of Medical Devices.解读美国医疗器械促进协会(AAMI)ST108标准中医疗器械安全处理的水质要求
AORN J. 2025 Feb;121(2):151-156. doi: 10.1002/aorn.14284.
9
[Standards used in the regulation of medical device in USA].[美国医疗器械监管中使用的标准]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Nov;21(11):1263-7.
10
Left to their own devices: breakdowns in United States medical device premarket review.放任自流:美国医疗器械上市前审查的崩溃。
PLoS Med. 2010 Jul 13;7(7):e1000280. doi: 10.1371/journal.pmed.1000280.

本文引用的文献

1
Identification and quantification of medical device extractables and leachables via non-target analysis (NTA); Analytical uncertainty.通过非靶向分析(NTA)鉴定和量化医疗器械浸出物和可提取物;分析不确定度。
J Pharm Biomed Anal. 2024 Apr 15;241:115985. doi: 10.1016/j.jpba.2024.115985. Epub 2024 Jan 19.
2
Applications of Fourier Transform-Infrared spectroscopy in microbial cell biology and environmental microbiology: advances, challenges, and future perspectives.傅里叶变换红外光谱在微生物细胞生物学和环境微生物学中的应用:进展、挑战及未来展望
Front Microbiol. 2023 Nov 21;14:1304081. doi: 10.3389/fmicb.2023.1304081. eCollection 2023.
3
Non-targeted analysis (NTA) and suspect screening analysis (SSA): a review of examining the chemical exposome.
非靶向分析(NTA)和可疑筛选分析(SSA):考察化学暴露组的研究综述。
J Expo Sci Environ Epidemiol. 2023 Jul;33(4):524-536. doi: 10.1038/s41370-023-00574-6. Epub 2023 Jun 28.
4
Matrix Effects in GC-MS Profiling of Common Metabolites after Trimethylsilyl Derivatization.三甲基硅烷化衍生化后 GC-MS 分析常见代谢物时的基质效应。
Molecules. 2023 Mar 15;28(6):2653. doi: 10.3390/molecules28062653.
5
A Systematic Analysis of the Effect of Extraction Solvents on the Chemical Composition of Extraction Solutions and the Analytical Implications in Extractables and Leachables Studies.一种萃取溶剂对萃取液化学成分影响的系统分析及其在浸出物和可提取物研究中的分析意义。
J Pharm Biomed Anal. 2023 Jan 5;222:115081. doi: 10.1016/j.jpba.2022.115081. Epub 2022 Sep 30.
6
Medical devices as a source of phthalate exposure: a review of current knowledge and alternative solutions.医疗器械作为邻苯二甲酸酯暴露的来源:当前知识和替代解决方案的综述。
Arh Hig Rada Toksikol. 2022 Sep 30;73(3):179-190. doi: 10.2478/aiht-2022-73-3639. eCollection 2022 Sep 1.
7
Report on investigation of ISO 10993-12 extraction conditions.ISO 10993-12提取条件调查研究报告
Regul Toxicol Pharmacol. 2022 Jun;131:105164. doi: 10.1016/j.yrtph.2022.105164. Epub 2022 Apr 2.
8
Chemical Characterization and Non-targeted Analysis of Medical Device Extracts: A Review of Current Approaches, Gaps, and Emerging Practices.医疗器械提取物的化学表征与非靶向分析:当前方法、差距及新兴实践综述
ACS Biomater Sci Eng. 2022 Mar 14;8(3):939-963. doi: 10.1021/acsbiomaterials.1c01119. Epub 2022 Feb 16.
9
Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part I-Development.液相色谱-串联质谱技术在临床实验室中的应用评价:第一部分——发展。
Ann Lab Med. 2022 Mar 1;42(2):121-140. doi: 10.3343/alm.2022.42.2.121.
10
Compensate for or Minimize Matrix Effects? Strategies for Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry Technique: A Tutorial Review.补偿或最小化基质效应?克服液相色谱-质谱技术中基质效应的策略:综述教程。
Molecules. 2020 Jul 3;25(13):3047. doi: 10.3390/molecules25133047.